window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 10, 2026

  • News
  • About Us
Contact Us

Real World Evidence

  • Diagnostics,Hematology,Oncology,Real world evidence

    Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring

    Quest Diagnostics has introduced a new blood-based test for measurable [...]

    February 4, 2026
  • Chronic diseases,Clinical Development

    Rapid sepsis test linked to lower mortality and shorter hospital stays in academic centre study

    A rapid sepsis test used in the emergency department at [...]

    December 10, 2025
  • Clinical Development,Clinical studies,Data Management,Technology and platforms

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    September 24, 2025
  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Regulatory Affairs

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    September 22, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Trials,Data Management,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    September 18, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Drug Delivery & Formulation,Technology and platforms

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    August 21, 2025
  • Clinical Trials,Data Management,Real world evidence,Regulatory Affairs

    Clinical trials: TransCelerate and FDA explore pragmatic trial designs to broaden patient access

    TransCelerate BioPharma and the US Food and Drug Administration (FDA) [...]

    August 20, 2025
  • Artificial Intelligence,Clinical Trials,Real world evidence,Research & Development

    AI in research and clinical trials: Speed, accuracy, and a smarter future

    AI is rapidly transforming how clinical trials are designed, run, [...]

    July 17, 2025
  • Movers & Shakers

    Phastar appoints industry veteran Billy Amzal as head of strategic consulting

    Biostatistics and real-world evidence expert joins global CRO to advance [...]

    June 25, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials
    Categories: Artificial Intelligence, Clinical Trials, Diagnostics, Oncology
  • DFE Pharma launches EcoLact 2030 to cut CO₂ emissions across lactose excipients
    Categories: Ingredients, Manufacturing, Pharmaceuticals and therapeutics, Sustainability
  • Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Respiratory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top